Nitric oxide involvement in regulating the dopamine transport in the striatal region of rat brain

Neurochemistry International

Volumn 31, Issue 4, 1997, Pages 607-616

  Chaparro Huerta, Veronica ^a   Beas Zárate, Carlos ^a,c   Guerrero, Monica Ureña ^a   Feria Velasco, Alfredo ^b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b CENTRO DE INVESTIGACIÓN Y ASISTENCIA EN TECNOLOGÍA Y DISEÑO DEL ESTADO DE JALISCO   (Mexico)

^c M Sci Carlos BEPS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ARGININE; DIZOCILPINE MALEATE; DOPAMINE; GAMMA GLUTAMYLAMINOMETHYLSULFONIC ACID; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; HISTIDINE; KAINIC ACID; LYSINE; N METHYL DEXTRO ASPARTIC ACID; N(G) NITROARGININE; NITRIC OXIDE; QUISQUALIC ACID; VALINE;

ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACIDS; ANIMALS; ARGININE; CARRIER PROTEINS; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0343247724     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00141-6     Document Type: Article

References (49)

1. Beas-zárate, C., Schliebs, R., Morales-Villagrán, A. and Feria-Velasco, A. (1989) Monosodium L-glutamate induced convulsion. Changes in uptake and release of catecholamines in cerebral cortex and caudate nucleus of adult rats. Epilepsy Res. 4, 20-27.
2. Blackstone, C. G. (1992) Excitatory amino acids and protein kinases. Neurosci. Facts. 3, 1-3.
3. Carlsson, M. and Carlsson, A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. TINS 13, 272-276.
4. Cepeda, C., Buchwald, N. A. and Levine, M. S. (1993) Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc. natl Acad. Sci U.S.A. 90, 9576-9580.
5. Chang, R. S. L., Tran, V. T. and Snyder, S. H. (1980) Neurotransmitter receptor localisations. Brain lesion induced alterations in benzodiazepine, GABA, β-adrenergic and histamine-H1 receptor binding. Brain Res. 190, 85-110.
6. Chesselet, M. F. (1984) Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience 12, 347-375.
7. Coyle, J. T. and Puttfarcken, P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
8. Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S. and Snyder, S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. natl. Acad. Sci. U.S.A. 88, 6368-6371.
9. Dawson, V. L., Dawson, T. M., Bartley, D. A., Uhl, G. R. and Snyder, S. H. (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13, 2651-2661.
10. DeLong, M. R. (1990) Primate models of movement disorders of basal ganglia origin. TINS 13, 281-285.
11. DiFiglia, M. (1990) Excitotoxic injury of the neostriatum: a model for Huntington's disease. TINS 13, 286-289.
12. G-nitroarginine in brain in vitro and in vivo. Biochem. Biophys. Res. Commun. 176, 1136-1141.
13. Fuller, R. W., Hemrick-Luecke, S. K. and Ornstein, P. L. (1992) Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist. Neuropharmacology 31, 1027-1032.
14. Fukuto, J. M. and Chaudhuri, G. (1995) Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Annu. Rev. Pharmac. Toxicol. 315, 165-194.
15. Garthwaite, J., Garthwaite, G., Palmer, R. M. J. and Moncada, S. (1989a) NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. Molec. Pharmac. Section 172, 413-416.
16. Garthwaite, J., Southam, E. and Anderton, M. (1989b) A kainate receptor linked to nitric oxide synthesis from arginine. J. Neurochem. 53, 1952-1954.
17. Gasic, G. P. and Hollman, M. (1992) Molecular neurobiology of glutamate receptors. Annu. Rev. Physiol. 54, 507-536.
18. Griffith, O. W. and Stuehr, D. J. (1995) Nitric oxide synthesis: properties and catalytic mechanism. Annu. Rev. Physiol. 57, 707-736.
19. 3H]-dopamine from striatal slices. Neuron Rep. 3, 409-412.
20. Hirsch, D. B., Steiner, J. P., Dawson, T. M., Mammen, A., Hayek, E. and Snyder, S. H. (1993) Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synaptosomes. Current Biol. 3, 749-754.
21. Hyman, B. T., Marzloff, K., Wenniger, J. J., Dawson, T. M., Bredt, D. S. and Snyder, S. H. (1992) Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Annu. Neurol. 32, 818-820.
22. Ischiropoulos, H., Zhu, L. and Beckman, J. S. (1992) Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298, 446-451.
23. Klatt, P., Schmidt, K., Brunner, F. and Mayer, B. (1994) Inhibitors of brain nitric oxide synthase: binding kinetics, metabolism, and enzyme inactivation. J. Biol. Chem. 269, 1674-1680.
24. Krebs, M. O., Desce, J. M., Kermel, M. L., Gaucy, C., Godeheu, G., Chéramy, A. and Glowinski, J. (1991) Glutamatergic control of dopamine release in the rat striatum: Evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56, 81-85.
25. Leviel, V., Gobert, A. and Guibert, B. (1990) The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function. Neuroscience 39, 305-312.
26. Lipton, S. A., Choi, Y. B., Pan, Z. H., Lei, S. Z., Chen, H. V., Sucher, N. J., Loscalzo, J., Singel, D. J. and Stamler, J. S. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626-632.
27. Lipton, S. A. and Rosenberg, R. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330, 613-622.
28. Manzoni, O. and Bockaert, J. (1993) Nitric oxide synthase activity endogenously modulates NMDA receptors. J. Neurochem. 61, 368-370.
29. Marin, P., Quignard, J-F., Lafon-Cazal, M. and Bockaert, J. (1993) Non-classical glutamate receptors, blocked by both NMDA and non-NMDA antagonists, stimulate nitric oxide production in neurons. Neuropharmacology 32, 29-36.
30. 2+-independent synaptic vesicle release. Neuron 12, 1235-1244.
31. Moncada, S., Palmer, R. M. J. and Higgs, E. A. (1989) Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem. Pharmacol. 38, 1709-1715.
32. Montague, P. R., Gancayco, C. D., Winn, M. J., Marchase, R. B. and Friedlander, M. J. (1994) Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263, 973-977.
33. 3H) GABA release from cerebral cortical neurons is mediated by peroxynitrite. J. Neurochem. 65, 1109-1114.
34. Puttfarcken, P. S., Lyons, W. E. and Coyle, J. T. (1992) Dissociation of nitric oxide generation and kainate-mediated neuronal degeneration in primary cultures of rat cerebellar granule cells. Neuropharmacology 31, 565-575.
35. Regan, R. F., Renn, K. E. and Panter, S. S. (1993) NMDA neurotoxicity in murine cortical cell cultures is not attenuated by hemoglobin or inhibition of nitric oxide synthesis. Neurosci. Lett. 153, 53-56.
36. 3H]-dopamine from rat striatal slice. Brain Res. 157, 391-395.
37. 3H]dopamine release from rat striatum: an in vitro model for glutamate actions. J. Neurochem. 32, 1539-1545.
38. Rock, D. M. and Macdonald, R. L. (1995) Polyamine regulation of N-methyl-D-aspartate receptor channels. Annu. Rev. Pharmacol. Toxicol. 35, 463-482.
39. Rothman, S. M. and Olney, J. M. (1987) Excitotoxicity and the NMDA receptor. TINS 10, 299-302.
40. Schmidt, K., Klatt, P. and Mayer, B. (1993) Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors. Molec. Pharmacol. 44, 615-621.
41. Schuman, E. M. and Madison, D. V. (1991) An inhibitor of nitric oxide synthetase prevents long-term potentiation (LTP). Soc, Neurosci. Abstr. 17, 2.
42. Shimizu, N., Duan, S., Hori, T. and Oomura, Y. (1990) Glutamate modulates dopamine release in the striatum as measured by brain microdialysis. Brain Res. Bull. 25, 99-102.
43. Stamler, J. S., Singel, D. J. and Loscalzo, J. (1992) Biochemistry of nitric oxide and its redox-activated forms. Science 258, 1898-1902.
44. Stuhlmiller, D. F. E. and Boje, K. M. K. (1995) Characterization of L-arginine and aminoguanidine uptake into isolated rat choroid plexus: differences in uptake mechanisms and inhibition by nitric oxide synthase inhibitors. J. Neurochem. 65, 68-74.
45. Surmeier, D. J., Eberwine, J., Wilson, C. J., Stefani, A. and Kitai, S. T. (1992) Dopamine receptor subtypes co-localize in rat striatonigral neurons. Proc. natl. Acad. Sci. U.S.A. 89, 10178-10182.
46. Surmeier, D. J. and Kitai, S. T. (1994) Dopaminergic regulation of striatal efferent pathways. Curr. Opin. Neurobiol. 4, 915-919.
47. 3H]arginine in cultured neurons. Characteristics and inhibition by nitric oxide synthase inhibitors. J. Neurochem. 61, 364-367.
48. Zhu, X. Z. and Luo, L. G. (1992) Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J. Neurochem. 59, 932-935.
49. Zigmond, M. J., Abercrombie, E. D., Berger, T. W., Grace, A. A. and Stricker, E. M. (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. TINS 13, 290-295.